This brief review summarizes the major proof-of-concept gene therapy studies for autosomal dominant retinitis pigmentosa (RP) caused by mutations in the rhodopsin gene (RHO-adRP) that have been conducted over the past 20 years in various animal models. We have listed in tabular form the various approaches, gene silencing reagents, gene delivery strategies, and salient results from these studies.
CITATION STYLE
Sudharsan, R., & Beltran, W. A. (2019). Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa. In Advances in Experimental Medicine and Biology (Vol. 1185, pp. 113–118). Springer. https://doi.org/10.1007/978-3-030-27378-1_19
Mendeley helps you to discover research relevant for your work.